Exercise to Improve Sleep in Parkinson's Disease
The Effects of Different Exercise Modalities on Sleep Quality and Architecture in People With Parkinson's Disease
McGill University
150 participants
Sep 1, 2021
INTERVENTIONAL
Conditions
Summary
This study will investigate the impact of three common exercise modalities, cardiovascular, resistance, and multimodal (i.e., a combination of the previous two) training, on sleep quality and architecture in persons with Parkinson's disease (PD). Furthermore, the project will investigate whether the potential positive exercise-induced changes in sleep are associated with improvements in different quality of life (QoL)-related aspects. Participants will perform either cardiovascular training (CT), resistance training (RT), multimodal training (MT), or will be allocated to a control condition (i.e., waiting list - CON) for 12 weeks. Training will be performed three times/week. The assessments will be conducted at baseline, post-intervention, and follow-up (i.e. 8 weeks after the intervention) by assessors blinded to the participants' group allocation.
Eligibility
Inclusion Criteria3
- Persons with mild-moderate idiopathic Parkinson's Disease (Modified Hoehn \& Yahr Scale stages 0.5-3.5);
- On a stable dosage of medication during the previous month;
- Having poor sleep quality defined as a score \> 15 in the PDSS-2 and/or reporting subjective sleep complaints affecting their sleep quality;
Exclusion Criteria8
- Having atypical parkinsonism, dementia, stroke, or any other neurological condition;
- Presenting severe untreated obstructive sleep apnea (OSA);
- Having a Montreal Cognitive Assessment (MoCA) score \<18
- Having a Beck Depression Inventory score \>31;
- Having absolute contraindications to exercise;
- Having severe osteoporosis;
- Participating in an exercise or drug trial during the period of the study;
- Exceeding the physical activity levels recommended for the general population (≥150 minutes/week of moderate-intensity or ≥75 minutes/week of vigorous-intensity cardiovascular activity) and/or strengthening activities ≥2 days/week.
Interventions
12 weeks of CT
12 weeks of RT
12 weeks of MT
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05644327